Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Knauer

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Clinical Chemistry and Laboratory Medicine|April 12, 2023
Establishing quality indicators for point of care glucose testing: recommendations from the Canadian Society for Clinical Chemists Point of Care Testing and Quality Indicators Special Interest GroupsJulie L V Shaw, Saranya Arnoldo, Lori Beach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2014
The PAM50 risk-of-recurrence score predicts risk for late distant recurrence after endocrine therapy in postmenopausal women with endocrine-responsive early breast cancerMartin Filipits, Torsten O Nielsen, Margaretha Rudas, et al.
NPJ Breast Cancer|January 27, 2026
Axillary surgery in patients with sentinel node macrometastases: secondary results of the randomized INSEMA trialToralf Reimer, Angrit Stachs, Kristina Veselinovic, et al.
Breast Cancer Research and Treatment|June 5, 2017
First international consensus conference on standardization of oncoplastic breast conserving surgeryWalter P Weber, Savas D Soysal, Mahmoud El-Tamer, et al.
Annals of Surgical Oncology|June 28, 2018
Impact of a Surgical Sealing Patch on Lymphatic Drainage After Axillary Dissection for Breast Cancer: The SAKK 23/13 Multicenter Randomized Phase III TrialWalter Paul Weber, Christoph Tausch, Stefanie Hayoz, et al.
Annals of Surgical Oncology|October 31, 2023
Impact of Imaging-Guided Localization on Performance of Tailored Axillary Surgery in Patients with Clinically Node-Positive Breast Cancer: Prospective Cohort Study Within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)Walter P Weber, Martin Heidinger, Stefanie Hayoz, et al.
Nature Cancer|January 17, 2025
Neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in women with early HER2-positive breast cancer: the randomized phase 2 ABCSG-52/ATHENE trialGabriel Rinnerthaler, Daniel Egle, Rupert Bartsch, et al.
Eclinicalmedicine|August 2, 2023
The Lucerne Toolbox 2 to optimise axillary management for early breast cancer: a multidisciplinary expert consensusOrit Kaidar-Person, André Pfob, Oreste Davide Gentilini, et al.
European Journal of Breast Health|April 19, 2021
Breast Cancer Management During the COVID-19 Pandemic: The Senologic International Society SurveyCarole Mathelin, Shanti Ame, Stanley Anyanwu, et al.
The Lancet. Oncology|January 2, 2021
Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolboxPeter Dubsky, Katja Pinker, Fatima Cardoso, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Clinical Chemistry and Laboratory Medicine|April 12, 2023
Establishing quality indicators for point of care glucose testing: recommendations from the Canadian Society for Clinical Chemists Point of Care Testing and Quality Indicators Special Interest GroupsJulie L V Shaw, Saranya Arnoldo, Lori Beach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2014
The PAM50 risk-of-recurrence score predicts risk for late distant recurrence after endocrine therapy in postmenopausal women with endocrine-responsive early breast cancerMartin Filipits, Torsten O Nielsen, Margaretha Rudas, et al.
NPJ Breast Cancer|January 27, 2026
Axillary surgery in patients with sentinel node macrometastases: secondary results of the randomized INSEMA trialToralf Reimer, Angrit Stachs, Kristina Veselinovic, et al.
Breast Cancer Research and Treatment|June 5, 2017
First international consensus conference on standardization of oncoplastic breast conserving surgeryWalter P Weber, Savas D Soysal, Mahmoud El-Tamer, et al.
Annals of Surgical Oncology|June 28, 2018
Impact of a Surgical Sealing Patch on Lymphatic Drainage After Axillary Dissection for Breast Cancer: The SAKK 23/13 Multicenter Randomized Phase III TrialWalter Paul Weber, Christoph Tausch, Stefanie Hayoz, et al.
Annals of Surgical Oncology|October 31, 2023
Impact of Imaging-Guided Localization on Performance of Tailored Axillary Surgery in Patients with Clinically Node-Positive Breast Cancer: Prospective Cohort Study Within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)Walter P Weber, Martin Heidinger, Stefanie Hayoz, et al.
Nature Cancer|January 17, 2025
Neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in women with early HER2-positive breast cancer: the randomized phase 2 ABCSG-52/ATHENE trialGabriel Rinnerthaler, Daniel Egle, Rupert Bartsch, et al.
Eclinicalmedicine|August 2, 2023
The Lucerne Toolbox 2 to optimise axillary management for early breast cancer: a multidisciplinary expert consensusOrit Kaidar-Person, André Pfob, Oreste Davide Gentilini, et al.
European Journal of Breast Health|April 19, 2021
Breast Cancer Management During the COVID-19 Pandemic: The Senologic International Society SurveyCarole Mathelin, Shanti Ame, Stanley Anyanwu, et al.
The Lancet. Oncology|January 2, 2021
Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolboxPeter Dubsky, Katja Pinker, Fatima Cardoso, et al.
Pageof 7